We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we ...

Results from the Phase III SPACE trial show that Ajovy significantly reduced monthly migraines in pediatric patients between ...

EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal ...

Teva Pharma (TEVA) stock gains as the company and Samsung Bioepis launch Epysqli, a biosimilar to AstraZeneca's (AZN) rare ...

Epysqli is used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia ...

Teva Pharmaceuticals (TEVA) and Samsung Bioepis (SSNLF) announced the availability of EPYSQLI in the U.S. EPYSQLI is a biosimilar to Soliris ...

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of Teva Pharmaceutical Industries in a ...

Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted its supplemental Biologics License Application ...

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Friday. Other equities ...